Shyamala Navada, MD, MSCR
-
- Position
- ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
-
- Specialties
- Hematology-Oncology
- Cancer (Oncology)
-
- Language
- English
-
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
-
- Phone
- Ruttenberg Treatment Center 212-241-6756 212-241-6756
-
Ruttenberg Treatment Center
1470 Madison Avenue
3rd Floor
New York, NY 10029
Phone: 212-241-6756212-241-6756
Shyamala Navada, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai (Icahn) and a faculty member of The Tisch Cancer Institute. Her focus is on clinical and translational research in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). She has worked on designing early phase clinical trials investigating the role of novel candidate drugs to improve the outcomes of patients with MDS and AML, and has served as principal investigator on multiple investigator-initiated and industry-sponsored trials. Dr. Navada has a Master of Science degree in Clinical Research from Icahn.
Dr. Navada has presented her research at national and international conferences, including the American Society of Hematology annual meeting, International Bone Marrow Failure Disease Scientific Symposium, International Symposium on Myelodysplastic Syndromes, and European Hematology Association Congress.
Dr. Navada is involved in education of community physicians and patients on the treatment of MDS through the Aplastic Anemia and MDS Foundation.
Clinical Focus
- Anemia
- Aplastic Anemia
- Blood Transfusion
- Bone Marrow Biopsy
- Leukemia
- Myelodysplastic Syndromes
- Primary Polycythemia
Research Topics
Cancer, Leukemia
Education
MD, University of Illinois
Residency, Internal Medicine
University of Michigan Hospitals
Fellowship, Hematology-Oncology
Mount Sinai Hospital
Language
English
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Navada during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Dova Pharmaceuticals
Scientific Advisory Board:
- Amgen Inc.
- Dova Pharmaceuticals
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.